[
  {
    "ts": null,
    "headline": "Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption",
    "summary": "EluPro™ Q2 revenue up 49% sequentially; Elutia advances next-generation drug-eluting biomatrix for breast reconstruction Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financial results for the second quarter of 2025. Since full launch in January 2025, EluPro has rapidly established itself as the",
    "url": "https://finnhub.io/api/news?id=448b1b7d07aac41f0b8c878da9587e0508418cfced95e43ec2d99584e1307b71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755201900,
      "headline": "Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption",
      "id": 136368163,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "EluPro™ Q2 revenue up 49% sequentially; Elutia advances next-generation drug-eluting biomatrix for breast reconstruction Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financial results for the second quarter of 2025. Since full launch in January 2025, EluPro has rapidly established itself as the",
      "url": "https://finnhub.io/api/news?id=448b1b7d07aac41f0b8c878da9587e0508418cfced95e43ec2d99584e1307b71"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=2242e2f66c087107313d9aa97cf58026eda04281e53151f0de4471d79a54a863",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755189300,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 136386913,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=2242e2f66c087107313d9aa97cf58026eda04281e53151f0de4471d79a54a863"
    }
  },
  {
    "ts": null,
    "headline": "Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y",
    "summary": "ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.",
    "url": "https://finnhub.io/api/news?id=2044a137d8dc3a8c40a1abb7a19974a7a71537c9790a175f09351cdc98db2032",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755184620,
      "headline": "Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y",
      "id": 136349409,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.",
      "url": "https://finnhub.io/api/news?id=2044a137d8dc3a8c40a1abb7a19974a7a71537c9790a175f09351cdc98db2032"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now",
    "summary": "HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.",
    "url": "https://finnhub.io/api/news?id=36fd06e7842566b3e164f5a4047f317d4d70d4a9f05e52fba4c200df20d308b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755183900,
      "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now",
      "id": 136349410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.",
      "url": "https://finnhub.io/api/news?id=36fd06e7842566b3e164f5a4047f317d4d70d4a9f05e52fba4c200df20d308b3"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Watchman device procedure risk",
    "summary": "The device's procedure-related incidents could have a negative impact on the company’s sales.",
    "url": "https://finnhub.io/api/news?id=45b39bb11b540ca59cafa3f27f0da7fa9e9f35efa31fef223dbc89170c587031",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755167529,
      "headline": "Boston Scientific Watchman device procedure risk",
      "id": 136344887,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The device's procedure-related incidents could have a negative impact on the company’s sales.",
      "url": "https://finnhub.io/api/news?id=45b39bb11b540ca59cafa3f27f0da7fa9e9f35efa31fef223dbc89170c587031"
    }
  }
]